lunlekitug

N/A

Report date: 2025/06/11 10:21:30

Base Information

Drug Namelunlekitug
Drug Alias NameIgG1 human monoclonal antibody (XBiotech)LM-216
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInterleukin-1 alpha inhibitors
TargetsInterleukin-1 alpha
Therapy Area/IndicationsInflammationCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXbiotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesXbiotech Inc
Inactive CompaniesN/A
Active IndicationsInflammationCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A